Average one-year price target for Xenon Pharmaceuticals was revised to $80.01, a 41.64% increase from the prior $56.49 target dated Feb 21, 2026. The move reflects aggregated analyst optimism (average of multiple targets) and could provide near-term upside to the stock, though it is analyst-driven rather than company-reported news.
Average one-year price target for Xenon Pharmaceuticals was revised to $80.01, a 41.64% increase from the prior $56.49 target dated Feb 21, 2026. The move reflects aggregated analyst optimism (average of multiple targets) and could provide near-term upside to the stock, though it is analyst-driven rather than company-reported news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
